Unknown

Dataset Information

0

Subclinical Left Ventricular Dysfunction Detected by Speckle-Tracking Echocardiography in Breast Cancer Patients Treated With Radiation Therapy: A Six-Month Follow-Up Analysis (MEDIRAD EARLY-HEART study).


ABSTRACT:

Background

In the case of breast cancer (BC), radiotherapy (RT) helps reduce locoregional recurrence and BC-related deaths but can lead to cardiotoxicity, resulting in an increased risk of long-term major cardiovascular events. It is therefore of primary importance to early detect subclinical left ventricular (LV) dysfunction in BC patients after RT and to determine the dose-response relationships between cardiac doses and these events.

Methods

Within the frame of the MEDIRAD European project (2017-2022), the prospective multicenter EARLY-HEART study (ClinicalTrials.gov Identifier: NCT03297346) included chemotherapy naïve BC women aged 40-75 years and treated with lumpectomy and adjuvant RT. Myocardial strain analysis was provided using speckle-tracking echocardiography performed at baseline and 6 months following RT. A global longitudinal strain (GLS) reduction >15% between baseline and follow-up was defined as a GLS-based subclinical LV dysfunction. Individual patient dose distributions were obtained using multi-atlas-based auto-segmentation of the heart. Dose-volume parameters were studied for the whole heart (WH) and left ventricle (LV).

Results

The sample included 186 BC women (57.5 ± 7.9 years, 64% left-sided BC). GLS-based subclinical LV dysfunction was observed in 22 patients (14.4%). These patients had significantly higher cardiac exposure regarding WH and LV doses compared to patients without LV dysfunction (for mean WH dose: 2.66 ± 1.75 Gy versus 1.64 ± 0.96 Gy, p = 0.01). A significantly increased risk of subclinical LV dysfunction was observed with the increase in the dose received to the WH [ORs from 1.13 (V5) to 1.74 (Dmean); p <0.01] and to the LV [ORs from 1.10 (V5) to 1.46 (Dmean); p <0.01]. Based on ROC analysis, the LV-V5 parameter may be the best predictor of the short-term onset of subclinical LV dysfunction.

Conclusion

These results highlighted that all cardiac doses were strongly associated with the occurrence of subclinical LV dysfunction arising 6 months after BC RT. Whether measurements of GLS at baseline and 6 months after RT combined with cardiac doses can early predict efficiently subclinical events occurring 24 months after RT remains to be investigated.

SUBMITTER: Locquet M 

PROVIDER: S-EPMC9275564 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature

altmetric image

Publications

Subclinical Left Ventricular Dysfunction Detected by Speckle-Tracking Echocardiography in Breast Cancer Patients Treated With Radiation Therapy: A Six-Month Follow-Up Analysis (MEDIRAD EARLY-HEART study).

Locquet Médéa M   Spoor Daan D   Crijns Anne A   van der Harst Pim P   Eraso Arantxa A   Guedea Ferran F   Fiuza Manuela M   Santos Susana Constantino Rosa SCR   Combs Stephanie S   Borm Kai K   Mousseaux Elie E   Gencer Umit U   Frija Guy G   Cardis Elisabeth E   Langendijk Hans H   Jacob Sophie S  

Frontiers in oncology 20220628


<h4>Background</h4>In the case of breast cancer (BC), radiotherapy (RT) helps reduce locoregional recurrence and BC-related deaths but can lead to cardiotoxicity, resulting in an increased risk of long-term major cardiovascular events. It is therefore of primary importance to early detect subclinical left ventricular (LV) dysfunction in BC patients after RT and to determine the dose-response relationships between cardiac doses and these events.<h4>Methods</h4>Within the frame of the MEDIRAD Euro  ...[more]

Similar Datasets

| S-EPMC7616760 | biostudies-literature
| S-EPMC11499540 | biostudies-literature
| S-EPMC10619803 | biostudies-literature
| S-EPMC4882839 | biostudies-other
| S-EPMC7416266 | biostudies-literature
| S-EPMC7961169 | biostudies-literature
| S-EPMC7724215 | biostudies-literature
| S-EPMC8302535 | biostudies-literature
| S-EPMC8523819 | biostudies-literature